Basecamp Research Secures $140 Million in Series C Funding Led by S32

Basecamp Research Raises $140 Million in Series C Funding

Basecamp Research, a London-based life sciences company, has announced a successful Series C funding round, raising $140 million. The round was led by S32, with notable participation from investors including Nvidia, Anthropic, Anthology Fund, Catalio, NATO Innovation Fund, Rockefeller, European Tech Collective, the UK government’s Sovereign AI Fund, Firebrand, River Capital King Philanthropies, and Redalpine.

About Basecamp Research

Basecamp Research is focused on pioneering the future of medicine by developing AI models and medicines designed to enable the human body to repair itself. Co-founded by Glen Gowers and Oliver Vince, the company is at the forefront of utilizing artificial intelligence to create innovative medical solutions.

Use of Funds

According to the company, the newly acquired funds will be used to train a new generation of AI models. This development aims to enhance the capabilities of their existing technology in the field of medicine.

Strategic Investors and Their Roles

S32, the lead investor, is joined by other significant players in the tech and investment sectors. Nvidia and Anthropic, both known for their advancements in AI technology, bring not only capital but also strategic expertise to Basecamp's endeavors. The involvement of the UK government’s Sovereign AI Fund highlights the national interest in supporting cutting-edge medical research.

Basecamp Research's innovative approach and significant backing position it as a key player in the evolving landscape of AI-driven medical advancements.